Literature DB >> 18617279

Differential expression of cytokines, chemokines and chemokine receptors in patients with coronary artery disease.

Rômulo Tadeu Dias de Oliveira1, Ronei Luciano Mamoni, José Roberto Matos Souza, Juliano Lara Fernandes, Francisco José O Rios, Magnus Gidlund, Otávio Rizzi Coelho, Maria Heloisa Souza Lima Blotta.   

Abstract

Monocytes/macrophages and lymphocytes have a key role in the pathogenesis of atherosclerosis through the production of inflammatory and anti-inflammatory cytokines. We evaluated mRNA expression and protein production of CCL2, CXCL8, CXCL9, CXCL10, IFN-gamma and IL-10 in vitro as well as the expression of the CCR2 and CXCR3 receptors in peripheral blood mononuclear cells (PBMCs) of patients with coronary artery disease (CAD) and healthy controls in the presence or absence of oxidized LDL (oxLDL). Patients with CAD showed higher constitutive expression of CCL2, CXCL8, CXCL9, CXCL10 and IFN-gamma mRNA and, after stimulation with oxLDL, higher expression of CCL2 and CXCL8 mRNA than the control group. We also detected higher levels of CCL2 and CXCL8 in supernatants of oxLDL-stimulated PBMCs from CAD patients than in corresponding supernatants from controls. Patients with CAD had a higher percentage of constitutive CCR2(+) and CXCR3(+) cells after stimulation with oxLDL. Among CAD patients, the main differences between the stable (SA) and unstable angina (UA) groups were lower IL-10 mRNA production in the latter group. Altogether, our data suggest that PBMCs from CAD patients are able to produce higher concentrations of chemokines and cytokines involved in the regulation of monocyte and lymphocyte migration and retention in atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617279     DOI: 10.1016/j.ijcard.2008.04.009

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  18 in total

1.  Associations of four circulating chemokines with multiple atherosclerosis phenotypes in a large population-based sample: results from the dallas heart study.

Authors:  Leticia Castillo; Anand Rohatgi; Colby R Ayers; Andrew W Owens; Sandeep R Das; Amit Khera; Darren K McGuire; James A de Lemos
Journal:  J Interferon Cytokine Res       Date:  2010-05       Impact factor: 2.607

Review 2.  The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue.

Authors:  Bonnie K Surmi; Alyssa H Hasty
Journal:  Vascul Pharmacol       Date:  2009-12-21       Impact factor: 5.773

Review 3.  Evolution, Expression and Functional Analysis of CXCR3 in Neuronal and Cardiovascular Diseases: A Narrative Review.

Authors:  Devi Satarkar; Chinmoy Patra
Journal:  Front Cell Dev Biol       Date:  2022-06-20

4.  Interferon-gamma increases the ratio of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in peripheral monocytes from patients with coronary artery disease.

Authors:  Rashidi Springall; Luis M Amezcua-Guerra; Hector Gonzalez-Pacheco; Janette Furuzawa-Carballeda; Lorena Gomez-Garcia; Ricardo Marquez-Velasco; Ana María Mejía-Domínguez; Jorge Cossío-Aranda; Carlos Martínez-Sánchez; Rafael Bojalil
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

Review 5.  The multifaceted functions of CXCL10 in cardiovascular disease.

Authors:  Pleunie van den Borne; Paul H A Quax; Imo E Hoefer; Gerard Pasterkamp
Journal:  Biomed Res Int       Date:  2014-04-23       Impact factor: 3.411

6.  Transcriptional Activity of Gene Encoding Subunits R1 and R2 of Interferon Gamma Receptor in Peripheral Blood Mononuclear Cells in Patients with Slow Coronary Flow.

Authors:  Sanaz Faramarz-Gaznagh; Yousef Rasmi; Mohammad-Hasan Khadem-Ansari; Mir-Hossein Seyed-Mohammadzad; Morteza Bagheri; Mohadeseh Nemati; Alireza Shirpoor; Ehsan Saboori
Journal:  J Med Biochem       Date:  2016-05-09       Impact factor: 3.402

Review 7.  The Role of CXCR3 and Associated Chemokines in the Development of Atherosclerosis and During Myocardial Infarction.

Authors:  Veronika Szentes; Mária Gazdag; István Szokodi; Csaba A Dézsi
Journal:  Front Immunol       Date:  2018-08-27       Impact factor: 7.561

8.  Association between cytokines and two circulating micro-RNAs and development of premature ventricular contractions-induced cardiomyopathy.

Authors:  Behshid Ghadrdoost; Nahid Aboutaleb; Mahin Nikougoftar Zarif; Mojdeh Nakhlestani; Majid Haghjoo; Shahram Sameie
Journal:  Iran J Basic Med Sci       Date:  2019-10       Impact factor: 2.699

Review 9.  The Role of MicroRNAs in Regulating Cytokines and Growth Factors in Coronary Artery Disease: The Ins and Outs.

Authors:  Armita Mahdavi Gorabi; Nasim Kiaie; Thozhukat Sathyapalan; Khalid Al-Rasadi; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  J Immunol Res       Date:  2020-07-25       Impact factor: 4.818

10.  BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes.

Authors:  Sylwia Wasiak; Kim E Dzobo; Brooke D Rakai; Yannick Kaiser; Miranda Versloot; Mahnoush Bahjat; Stephanie C Stotz; Li Fu; Michael Sweeney; Jan O Johansson; Norman C W Wong; Erik S G Stroes; Jeffrey Kroon; Ewelina Kulikowski
Journal:  Clin Epigenetics       Date:  2020-11-11       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.